A New Era in Pharmacovigilance: Toward Real‐World Data and Digital Monitoring-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A New Era in Pharmacovigilance: Toward Real‐World Data and Digital Monitoring

Published:2021-02-28 Issue:5 Volume:109 Page:1197-1202
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Lavertu Adam¹,Vora Bianca²,Giacomini Kathleen M.²,Altman Russ³⁴,Rensi Stefano³

Affiliation:

1. Biomedical Informatics Training Program Stanford University Stanford California USA

2. Department of Bioengineering and Therapeutic Sciences University of California, San Francisco San Francisco California USA

3. Department of Bioengineering Stanford University Stanford California USA

4. Departments of Biomedical Data Science, Genetics, and Medicine Stanford University Stanford California USA

Funder

National Science Foundation

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2172

Reference24 articles.

1. When good drugs go bad

2. Postmarket Safety Outcomes for New Molecular Entity (NME) Drugs Approved by the Food and Drug Administration Between 2002 and 2014

3. Evaluation of FDA safety-related drug label changes in 2010

4. The FDA Sentinel Initiative — An Evolving National Resource

5. Center for Drug Evaluation Research FDA D.I.S.C.O.Avelumab in Merkel Cell Carcinoma Transcript (2020).

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers in reporting adverse effects of medical devices: a literature review;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-11

2. A discovery and verification approach to pharmacovigilance using electronic healthcare data;Frontiers in Pharmacology;2024-09-04

3. A Real‑World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten;American Journal of Cardiovascular Drugs;2024-08-21

4. Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies;Frontiers in Pharmacology;2024-08-20

5. Serious gaming as potential training tool for recognition of adverse drug reactions: side-effect exposure—medical education (SeeMe);European Journal of Clinical Pharmacology;2024-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3